Journal
LIGHT-SCIENCE & APPLICATIONS
Volume 11, Issue 1, Pages -Publisher
SPRINGERNATURE
DOI: 10.1038/s41377-022-00794-9
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [22020102003, 52022094, 21834007, 51502284, 5207214, 21673220]
- National Key R&D Program of China [2020YFA0712102]
- Youth Innovation Promotion Association of Chinese Academy of Sciences [2019232]
Ask authors/readers for more resources
The specific diagnosis and treatment of gliomas is a challenge in clinic. In this study, a core-shell structured nanotheranostic agent YHM was designed and constructed for diagnosis and treatment of gliomas. The YHM showed good BBB penetration, NIR-II/MRI bimodality imaging, and efficient SDT. This work provides insights into exploring theranostic agents for gliomas based on rare earth-doped yttrium vanadate nanoparticles.
The specific diagnosis and treatment of gliomas is a primary challenge in clinic due to their high invasiveness and blood-brain barrier (BBB) obstruction. It is highly desirable to find a multifunctional agent with good BBB penetration for precise theranostics. Herein, we design and construct a core-shell structured nanotheranostic agent (YVO4:Nd3+-HMME@MnO2-LF, marked as YHM) with YVO4:Nd3+ particles as the core and MnO2 nanosheets as the shell. Sonosensitizer hematoporphyrinmonomethyl ether (HMME) and lactoferrin (LF) were further loaded and modified on the surface, giving it a good ability to cross the BBB, near-infrared fluorescence imaging in the second window (NIR-II)/magnetic resonance imaging (MRI) bimodality, and highly efficient sonodynamic therapy (SDT) of orthotopic gliomas. The YVO4:Nd3+ (25%) core exhibited good NIR-II fluorescence properties, enabling YHM to act as promising probes for NIR-II fluorescence imaging of vessels and orthotopic gliomas. MnO2 shell can not only provide O-2 in the tumor microenvironments (TME) to significantly improve the healing efficacy of SDT, but also release Mn2+ ions to achieve T-1-weight MRI in situ. Non-invasive SDT can effectively restrain tumor growth. This work not only demonstrates that multifunctional YHM is promising for diagnosis and treatment of orthotopic glioma, but also provides insights into exploring the theranostic agents based on rare earth-doped yttrium vanadate nanoparticles.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available